These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7328768)

  • 1. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
    Yamada K; Suzuki H; Kato Y
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1080-5. PubMed ID: 7331685
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J
    Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
    Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
    Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Kimura K; Yamada K; Uzuka Y; Maekawa T; Takaku F; Shimoyama M; Ogawa M; Amaki I; Osamura S; Ito M; Sakai Y; Oguro M; Hattori K; Hoshino A; Hirota Y; Ohta K; Nakamura T; Masaoka T; Kimura I; Ichimaru M
    Recent Results Cancer Res; 1981; 76():232-40. PubMed ID: 7232852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
    Kimura K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) by 30-minute infusion with acute nonlymphocytic leukemia--the possibility of administration for outpatients].
    Hirosawa S
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1991-3. PubMed ID: 3164182
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T; Nakamura S; Ohtake S; Ito K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
    Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
    Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
    Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M
    Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
    Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
    Takubo T; Tani Y; Kubota Y; Oguma S; Ueda T; Nakamura H; Shibata H; Masaoka T
    Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):1-7. PubMed ID: 6597236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Yamada K; Kawashima K; Kato Y; Morishima Y; Tanimoto M; Ohno R
    Recent Results Cancer Res; 1980; 70():219-29. PubMed ID: 6766563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine after intraperitoneal administration].
    Noda T; Oku M; Kiyozuka Y; Maruyama M; Adachi S; Akada S; Okamura Y; Ichijo M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2929-35. PubMed ID: 3178241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment with a small dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in a case of chronic myelomonocytic leukemia in blastic crisis].
    Tsukada J; Misago M; Sato T; Kikuchi M; Nakata K; Nagata K; Mori N; Otani H; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jan; 30(1):61-6. PubMed ID: 2716200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes].
    Moriguchi T; Kakita T; Nishimura T; Kubo A; Ueda T; Nakamura T; Sasada M; Uchino H
    Rinsho Ketsueki; 1987 Sep; 28(9):1568-75. PubMed ID: 3437519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.